DAIWA PHARMACEUTICAL CO., LTD. Trademark Portfolio

Name: DAIWA PHARMACEUTICAL CO., LTD. USPTO Trademark Portfolio
Creator: GleanMark
License: https://www.usa.gov/government-works
Keywords: trademark portfolio, USPTO, intellectual property, DAIWA PHARMACEUTICAL CO., LTD.

DAIWA PHARMACEUTICAL CO., LTD. owns 11 live USPTO trademarks across 4 Nice classes. Earliest filing: 1995-02-13; most recent: 2025-07-23.

Portfolio Overview

Total Marks	38
Live Marks	11
Registered	10
Pending	1
Earliest Filing	1995-02-13
Latest Filing	2025-07-23

Top Classes

Class 005 (Pharmaceuticals), Class 042 (Software & IT), Class 029 (Meats & Dairy), Class 031 (Agriculture)

Recently Registered Marks

HSOP — registered 2024-10-29
RBAC — registered 2020-05-05
MGN-3 — registered 2019-09-17
KEFIRAN RTS — registered 2016-01-05
IPRAXIC — registered 2009-11-03

Recently Filed Applications

HS-1 — filed 2025-07-23 (Pending)
HSOP — filed 2023-12-07 (Registered)
HSOP — filed 2021-04-08 (Abandoned)
MGN-3 — filed 2017-09-12 (Registered)
RBAC — filed 2016-09-09 (Registered)

Top Marks

HSOP — Registered
RBAC — Registered
MGN-3 — Registered
KEFIRAN RTS — Registered
IPRAXIC — Registered
PLASMANEX 1 — Registered
THE TRUSTED, PROVEN FORMULA FOR IMMUNE SUPPORT. — Registered
PEAKIMMUNE4 — Registered
BRM4 — Registered
HRB — Cancelled
NKCP — Cancelled
MGN 3 — Cancelled
LENTINPLUS — Cancelled
DHD — Cancelled
BIOBRAN — Registered
HS-1 — Pending
HSOP — Abandoned
NKCP — Abandoned
MGN-3 — Abandoned
BIOGENICS — Abandoned
RBAC — Abandoned
NKCP — Abandoned
BIOGENICS — Abandoned
MGN-3 — Abandoned
RBAC — Abandoned
KEFIRAN — Abandoned
DAIWASOY ENZYME — Abandoned
BFPB — Abandoned
LEUCOMODULIN — Abandoned
RBAC — Abandoned
MGN-3 — Abandoned
AAGA — Abandoned
PHYTOGALACTOGLUCAN — Abandoned
NATTOPROTEASE — Abandoned
RICEKEFIRAN — Abandoned
PHYTOKEFIRAN — Abandoned
KEFIRAN — Abandoned
NATTO — Abandoned